Sicor Inc.

SICOR invites you to join its first quarter 2001 conference call on the web

    Irvine, California (ots-PRNewswire) - In conjunction with SICOR Inc.'s (Nasdaq: SCRI) first quarter 2001 financial results press release, you are invited to listen to its conference call that will be broadcast live over the Internet on Thursday, April 26, 2001 at 12:00 p.m. Eastern Time.

    What:      SICOR Inc. First Quarter Financial Results
    When:      12:00 p.m. Eastern on Thursday, April 26, 2001

    Where: under "Investor Resources and

    How:        Live over the Internet -- Simply log on to the web at
                  the address above

    Contact: SICOR Investor Relations
                  Phone +1 949-455-4879

    If you are unable to participate during the live webcast, the call will be archived on the Web site for approximately seven days. To access the replay, follow the SICOR Inc. link to the Investor Resources web page. From this page you will find a link to the replay under "Conference Calls and Presentations" web page. The Call will also be available until 1:00 a.m. Eastern Sunday, April 29, 2001 by calling +1 (888) 203-1112, or +1 719 457 0820 if from an international phone, with pass code 624542.

    SICOR Inc. is a vertically integrated speciality pharmaceutical company with proven expertise in the development, manufacturing and marketing of multi-source injectable pharmaceuticals. With a strategy of combining both the production of active pharmaceutical ingredients utilising chemical synthesis or fermentation and state of the art manufacturing facilities, SICOR's primary focus is on the worldwide injectable pharmaceutical market, which currently includes oncology, anaesthesiology, cardiology and other therapeutic areas. SICOR operates several manufacturing facilities in Europe, Mexico and the U.S.A., while maintaining the corporate headquarters in Irvine, California.

ots Originaltext: SICOR Inc.

Laurie W. Little of SICOR Inc., phone +1 949-455-4879

Company News On-Call: or
fax, +1 800 758-5804, ext. 354050


Das könnte Sie auch interessieren: